The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company focused on treating muscle wasting disorders.

Total Raised

$16 M

Rounds

3

Links

Verticals

Biotechnology
Medical
Pharmaceutical

Investment History

  1. Series A

    Oct 2024

    $6M

  2. Series A

    Jun 2023

    $6M

  3. Seed

    Jun 2021

    $4M

Team

Robin Bhattacherjee

Chief Executive Officer

Andrew Coats

Founder and Non-Executive Director

Stefan D. Anker

Co-Founder and Chair of Scientific Advisory Board

Frank Misselwitz

Chief Medical Officer and Member Board Of Directors